Detalles de la búsqueda
1.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
N Engl J Med
; 386(12): 1132-1142, 2022 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179323
2.
Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function.
Int Immunol
; 36(4): 167-182, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38169425
3.
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.
Proc Natl Acad Sci U S A
; 119(7)2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35140181
4.
The activated complement pathway in the fibrous process of benign prostatic hyperplasia.
Prostate
; 84(2): 203-211, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37876324
5.
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study.
Jpn J Clin Oncol
; 54(5): 584-591, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305451
6.
Increased toxicities associated with dose escalation of stereotactic body radiation therapy in prostate cancer: results from a phase I/II study.
Acta Oncol
; 62(5): 488-494, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37203203
7.
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in Japan.
Int J Urol
; 30(9): 723-729, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36578154
8.
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional study.
Int J Urol
; 30(1): 70-76, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305578
9.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Int J Urol
; 30(9): 762-771, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248753
10.
Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Int J Urol
; 30(11): 1044-1050, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37522577
11.
Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia.
Int J Mol Sci
; 24(14)2023 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511400
12.
Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2-Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat.
Int J Mol Sci
; 24(4)2023 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835398
13.
High-fat diet promotes prostate cancer growth through histamine signaling.
Int J Cancer
; 151(4): 623-636, 2022 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403732
14.
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
Cancer Sci
; 113(5): 1830-1842, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293110
15.
EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer.
Br J Cancer
; 127(7): 1312-1323, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35794239
16.
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1103-1115, 2019 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30779531
17.
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
Cancer Immunol Immunother
; 71(12): 2999-3011, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598195
18.
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
BJU Int
; 130(2): 226-234, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110696
19.
Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study.
BMC Urol
; 22(1): 59, 2022 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413902
20.
Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers.
Int J Clin Oncol
; 27(4): 774-780, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35119579